Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Immulina Supplements on Inflammatory Biomarkers Correlated With Clinical Symptoms in Patients With Long COVID (PASC)

NCT05524532 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.

NCT NCT05524532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05524532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Immulina Supplements on Inflammatory Biomarkers Correlated With Clinical Symptoms in Patients With Long COVID (PASC)
Lead sponsor
University of Mississippi Medical Center
Phase
Phase 3
Overall status
Completed
Start date
July 20, 2023
Completion date
July 29, 2025
Enrollment
101 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

post acute covid-19 syndrome